The Broughton Group said yesterday it had launched Broughton Nicotine Services, a spin-off from Broughton Laboratories that will specialize in ‘accelerating safer nicotine-delivery products to market; advancing a smoke-free future’.
‘The launch coincides with the development of a 15,000 ft2 CRO [contract research organization] facility (pictured – Karen Ross Photography Studio) in Lancashire [UK] designed specifically to address the needs of the Electronic Nicotine Delivery Systems (ENDS) market,’ Broughton said in a press note.
‘Having operated in this rapidly expanding and changing market for almost 10 years, the company is now perfectly placed to guide ENDS companies through a period of growth and regulatory change.
‘Broughton Nicotine Services raised over £5 million in 2018 to invest in the new facility which includes several specialist laboratories equipped with the latest aerosol collection instruments, high-spec analytical equipment and fully validated software data management systems.
‘An impressive stand-alone stability facility covering all ICH [International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use] storage requirements has been included in this initial phase of developments.
‘Led by a growing team of experienced scientists and analytical chemists, the operation is aligned with capacity for further expansion during 2019 to meet the expectations of its global client base.’
Chief executive Dr. Paul Moran was quoted as saying that there had been a rapid change during recent years within the reduced-risk nicotine products market. “At Broughton Nicotine Services, we are committed to supporting this evolving industry towards creating a smoke-free future through innovations, scientific advancement and regulatory compliance,” he said. “Operating as an independent company within the Broughton Group, specialising in next generation nicotine delivery, will enable us to continue to accelerate the transformation of this exciting industry for our clients.”